Related Experiment Videos

Defining "High Risk" for Men with Localized Prostate Cancer: How Close Can Clinical Parameters Get Us?

Ross J Mason¹, Steven Joniau², R Jeffrey Karnes¹

¹Department of Urology, Mayo Clinic, Rochester, MN, USA.

European Urology Oncology

|May 18, 2019

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

IRE1 activity is prognostic in localised and metastatic prostate cancer and affects epithelial lineage states.

EMBO molecular medicine·2026

From High Cost to High Access: The Impact of Generic Abiraterone on Medicare Part D Spending in Advanced Prostate Cancer.

Urology practice·2026

ERBB2 copy number alterations and protein expression in bladder cancer treated by cystectomy.

Human pathology·2026

A Pilot Study of Ex-vivo High Frequency Ultrasound and Core Needle Biopsy to Improve Clinical Tumor Staging of Cancer of the Bladder.

Urology·2026

Salvage prostatectomy for locally recurrent prostate cancer after radiation: a narrative review of indications, outcomes, and surgical advancements.

World journal of urology·2026

Outcomes of Patients With Favorable Intermediate Risk Gleason Grade Group 2 Prostate Cancer Undergoing Radical Prostatectomy in the MRI Era: Refining Active Surveillance Selection Criteria.

The Prostate·2026

See all related articles